![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 9/00 | |
A61K 9/16 | |||
A61K 31/55 | |||
A61K 9/14 |
(11) | Number of the document | 2941242 |
(13) | Kind of document | T |
(96) | European patent application number | 13829043.2 |
Date of filing the European patent application | 2013-12-27 | |
(97) | Date of publication of the European application | 2015-11-11 |
(45) | Date of publication and mention of the grant of the patent | 2017-02-01 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/JP2013/085355 |
Date | 2013-12-27 |
(87) | Number | WO 2014/104412 |
Date | 2014-07-03 |
(30) | Number | Date | Country code |
201261747005 P | 2012-12-28 | US |
(72) |
KANEKO, Daiki, JP
MATSUDA, Takakuni, JP
MIYATA, Kenichi, JP
SUZUKI, Kai, JP
FUJIKI, Hiroyuki, JP
KINOSHITA, Shizuo, JP
OHMOTO, Koji, JP
AIHARA, Miki, JP
|
(73) |
Otsuka Pharmaceutical Co., Ltd.,
9, Kanda-Tsukasamachi 2-chome Chiyoda-ku, Tokyo 101-8535,
JP
|
(54) | INJECTABLE DEPOT FORMULATION COMPRISING OPTICALLY ACTIVE TOLVAPTAN AND PROCESS OF PRODUCING THE SAME |
INJECTABLE DEPOT FORMULATION COMPRISING OPTICALLY ACTIVE TOLVAPTAN AND PROCESS OF PRODUCING THE SAME |